Published in Am J Psychiatry on August 01, 2002
Self-referential cognition and empathy in autism. PLoS One (2007) 1.88
Self-referenced processing, neurodevelopment and joint attention in autism. Autism (2010) 1.08
Autobiographical memory and social problem-solving in Asperger syndrome. J Autism Dev Disord (2007) 0.97
Dysfunctions in brain networks supporting empathy: an fMRI study in adults with autism spectrum disorders. Soc Neurosci (2010) 0.95
Episodic and semantic autobiographical memory in adults with autism spectrum disorders. J Autism Dev Disord (2007) 0.95
Brief report: relationship between self-awareness of real-world behavior and treatment outcome in autism spectrum disorders. J Autism Dev Disord (2012) 0.91
Self-referenced memory, social cognition, and symptom presentation in autism. J Child Psychol Psychiatry (2009) 0.91
The amygdala and the relevance detection theory of autism: an evolutionary perspective. Front Hum Neurosci (2013) 0.90
Episodic memory retrieval for story characters in high-functioning autism. Mol Autism (2013) 0.89
Neural and behavioral responses during self-evaluative processes differ in youth with and without autism. J Autism Dev Disord (2013) 0.88
Neural correlates of own name and own face detection in autism spectrum disorder. PLoS One (2014) 0.87
Eyewitness testimony in autism spectrum disorder: a review. J Autism Dev Disord (2014) 0.83
Brief report: do individuals with autism spectrum disorder think they know their own minds? J Autism Dev Disord (2008) 0.81
Memory for self-performed actions in individuals with Asperger syndrome. PLoS One (2010) 0.81
Sensory experiences of children with autism spectrum disorder: in their own words. Autism (2014) 0.79
Autistic empathy toward autistic others. Soc Cogn Affect Neurosci (2014) 0.78
The sense of agency in autism spectrum disorders: a dissociation between prospective and retrospective mechanisms? Front Psychol (2015) 0.75
The salience of the self: Self-referential processing and internalizing problems in children and adolescents with autism spectrum disorder. Autism Res (2016) 0.75
Is it me? Self-recognition bias across sensory modalities and its relationship to autistic traits. Mol Autism (2015) 0.75
Delayed Self Recognition in Autism: A Unique Difficulty? Res Autism Spectr Disord (2012) 0.75
Self make-up: the influence of self-referential processing on attention orienting. Sci Rep (2015) 0.75
Name recognition in autism: EEG evidence of altered patterns of brain activity and connectivity. Mol Autism (2016) 0.75
Emotion Perception Mediates the Predictive Relationship Between Verbal Ability and Functional Outcome in High-Functioning Adults with Autism Spectrum Disorder. J Autism Dev Disord (2017) 0.75
Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science (2008) 20.68
Treatment guidelines for children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry (2005) 3.79
A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents. Am J Psychiatry (2006) 3.68
A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents. Am J Psychiatry (2004) 3.44
Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) study. Am J Psychiatry (2008) 3.30
Meta-analysis of intellectual and neuropsychological test performance in attention-deficit/hyperactivity disorder. Neuropsychology (2004) 2.74
Validation of proposed DSM-5 criteria for autism spectrum disorder. J Am Acad Child Adolesc Psychiatry (2011) 2.72
Postpartum depression: a randomized trial of sertraline versus nortriptyline. J Clin Psychopharmacol (2006) 2.64
Fluoxetine treatment for prevention of relapse of depression in children and adolescents: a double-blind, placebo-controlled study. J Am Acad Child Adolesc Psychiatry (2004) 2.63
Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry (2007) 2.49
Regulation of osteoclast apoptosis by ubiquitylation of proapoptotic BH3-only Bcl-2 family member Bim. EMBO J (2003) 2.30
Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics (2009) 2.13
Comprehensive comparison of self-administered questionnaires for measuring quantitative autistic traits in adults. J Autism Dev Disord (2014) 2.13
Multiple roles of Rev3, the catalytic subunit of polzeta in maintaining genome stability in vertebrates. EMBO J (2003) 2.12
Growing evidence to support early intervention in early onset bipolar disorder. Aust N Z J Psychiatry (2007) 2.09
RAD18 and RAD54 cooperatively contribute to maintenance of genomic stability in vertebrate cells. EMBO J (2002) 2.06
The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry (2013) 1.97
Meta-analysis of epidemiologic studies of pediatric bipolar disorder. J Clin Psychiatry (2011) 1.85
ADHD and achievement: meta-analysis of the child, adolescent, and adult literatures and a concomitant study with college students. J Learn Disabil (2007) 1.85
Venlafaxine ER for the treatment of pediatric subjects with depression: results of two placebo-controlled trials. J Am Acad Child Adolesc Psychiatry (2007) 1.82
Vertebrate POLQ and POLbeta cooperate in base excision repair of oxidative DNA damage. Mol Cell (2006) 1.79
Review and meta-analysis of the phenomenology and clinical characteristics of mania in children and adolescents. Bipolar Disord (2005) 1.78
Behavioral outcomes and evidence of psychopathology among very low birth weight infants at age 20 years. Pediatrics (2004) 1.73
Efficacy and tolerability of second-generation antipsychotics in children and adolescents with schizophrenia. Schizophr Bull (2007) 1.69
Risperidone in children with disruptive behavior disorders and subaverage intelligence: a 1-year, open-label study of 504 patients. J Am Acad Child Adolesc Psychiatry (2005) 1.69
Characteristics of children with elevated symptoms of mania: the Longitudinal Assessment of Manic Symptoms (LAMS) study. J Clin Psychiatry (2010) 1.67
Double-blind 18-month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. J Am Acad Child Adolesc Psychiatry (2005) 1.64
Validation of the Mood Disorder Questionnaire for bipolar disorders in adolescents. J Clin Psychiatry (2006) 1.64
Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part I: a review. J Am Acad Child Adolesc Psychiatry (2003) 1.63
Neurocognitive outcomes in the Treatment of Early-Onset Schizophrenia Spectrum Disorders study. J Am Acad Child Adolesc Psychiatry (2012) 1.62
Brain lateralization of emotional processing: historical roots and a future incorporating "dominance". Behav Cogn Neurosci Rev (2005) 1.61
Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence. Am J Psychiatry (2002) 1.60
Pediatric bipolar disorder: validity, phenomenology, and recommendations for diagnosis. Bipolar Disord (2008) 1.59
Gender differences in criminality: bipolar disorder with co-occurring substance abuse. J Am Acad Psychiatry Law (2005) 1.59
Developing a 10-item mania scale from the Parent General Behavior Inventory for children and adolescents. J Clin Psychiatry (2008) 1.58
Comparing diagnostic checklists for pediatric bipolar disorder in academic and community mental health settings. Bipolar Disord (2005) 1.56
Toward an evidence-based assessment of pediatric bipolar disorder. J Clin Child Adolesc Psychol (2005) 1.50
Comparing the diagnostic accuracy of six potential screening instruments for bipolar disorder in youths aged 5 to 17 years. J Am Acad Child Adolesc Psychiatry (2004) 1.48
Barriers to the identification and management of psychosocial issues in children and maternal depression. Pediatrics (2007) 1.48
Discriminative validity of a parent version of the Young Mania Rating Scale. J Am Acad Child Adolesc Psychiatry (2002) 1.48
Longitudinal Assessment of Manic Symptoms (LAMS) study: background, design, and initial screening results. J Clin Psychiatry (2010) 1.47
Guns, adolescents, and mental illness. Am J Psychiatry (2008) 1.46
Internal consistency and associated characteristics of informant discrepancies in clinic referred youths age 11 to 17 years. J Clin Child Adolesc Psychol (2011) 1.46
rAAV-mediated shRNA ameliorated neuropathology in Huntington disease model mouse. Biochem Biophys Res Commun (2006) 1.45
Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis. J Neurosci (2002) 1.45
Mania with and without depression in a community sample of US adolescents. Arch Gen Psychiatry (2012) 1.41
Prevention of postpartum depression: a pilot randomized clinical trial. Am J Psychiatry (2004) 1.40
Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part II. J Am Acad Child Adolesc Psychiatry (2003) 1.39
International consensus statement on attention-deficit/hyperactivity disorder (ADHD) and disruptive behaviour disorders (DBDs): clinical implications and treatment practice suggestions. Eur Neuropsychopharmacol (2004) 1.38
Consensus report on impulsive aggression as a symptom across diagnostic categories in child psychiatry: implications for medication studies. J Am Acad Child Adolesc Psychiatry (2007) 1.36
Comparison of increasingly detailed elicitation methods for the assessment of adverse events in pediatric psychopharmacology. J Am Acad Child Adolesc Psychiatry (2004) 1.34
Juvenile maladaptive aggression: a review of prevention, treatment, and service configuration and a proposed research agenda. J Clin Psychiatry (2006) 1.31
Cell and gene therapy using mesenchymal stem cells (MSCs). J Autoimmun (2008) 1.30
Calpain-mediated X-linked inhibitor of apoptosis degradation in neutrophil apoptosis and its impairment in chronic neutrophilic leukemia. J Biol Chem (2002) 1.29
A double-blind, placebo-controlled study of modified-release methylphenidate in children with attention-deficit/hyperactivity disorder. Pediatrics (2002) 1.28
Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a consensus statement. J Clin Psychiatry (2010) 1.27
Mood state at study entry as predictor of the polarity of relapse in bipolar disorder. Biol Psychiatry (2004) 1.27
Exploratory and confirmatory factor analysis of the autism diagnostic interview-revised. J Autism Dev Disord (2007) 1.26
Factor structure of the Young Mania Rating Scale for use with youths ages 5 to 17 years. J Clin Child Adolesc Psychol (2002) 1.26
Concerns regarding the inclusion of temper dysregulation disorder with dysphoria in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. J Clin Psychiatry (2011) 1.25
Development of new inbred transgenic strains of rats with LacZ or GFP. Biochem Biophys Res Commun (2005) 1.24
Examining the proposed disruptive mood dysregulation disorder diagnosis in children in the Longitudinal Assessment of Manic Symptoms study. J Clin Psychiatry (2012) 1.23
Who are the comorbid adolescents? Agreement between psychiatric diagnosis, youth, parent, and teacher report. J Abnorm Child Psychol (2003) 1.23
A new noninvasive measurement system for wave intensity: evaluation of carotid arterial wave intensity and reproducibility. Heart Vessels (2002) 1.22
alpha2-Adrenergic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: emerging concepts from new data. J Child Adolesc Psychopharmacol (2007) 1.21
Transduction efficiency and immune response associated with the administration of AAV8 vector into dog skeletal muscle. Mol Ther (2008) 1.21
Medical comorbidity in bipolar disorder: relationship between illnesses of the endocrine/metabolic system and treatment outcome. Bipolar Disord (2010) 1.21
Early symptoms of mania and the role of parental risk. Bipolar Disord (2005) 1.20
Interleukin-10 expression mediated by an adeno-associated virus vector prevents monocrotaline-induced pulmonary arterial hypertension in rats. Circ Res (2007) 1.18
Employing parent, teacher, and youth self-report checklists in identifying pediatric bipolar spectrum disorders: an examination of diagnostic accuracy and clinical utility. J Child Adolesc Psychopharmacol (2003) 1.18
Sexual reproduction is the default mode in apomictic Hieracium subgenus Pilosella, in which two dominant loci function to enable apomixis. Plant J (2011) 1.16
Double-blind randomized trial of risperidone versus divalproex in pediatric bipolar disorder. Bipolar Disord (2010) 1.15
A quantitative and qualitative review of neurocognitive performance in pediatric bipolar disorder. J Child Adolesc Psychopharmacol (2008) 1.15
Clinical usefulness of carotid arterial wave intensity in assessing left ventricular systolic and early diastolic performance. Heart Vessels (2003) 1.15
The latent structure of attention-deficit/hyperactivity disorder in a clinic-referred sample. Neuropsychology (2007) 1.14
Altered white matter fractional anisotropy and social impairment in children with autism spectrum disorder. Brain Res (2010) 1.13
Review of safety assessment methods used in pediatric psychopharmacology. J Am Acad Child Adolesc Psychiatry (2003) 1.13
Double-blind, placebo-controlled trial of divalproex monotherapy in the treatment of symptomatic youth at high risk for developing bipolar disorder. J Clin Psychiatry (2007) 1.13
Effects of adolescent manic symptoms on agreement between youth, parent, and teacher ratings of behavior problems. J Affect Disord (2004) 1.13
How can we improve the assessment of safety in child and adolescent psychopharmacology? J Am Acad Child Adolesc Psychiatry (2003) 1.12
The co-occurrence of major depressive disorder among individuals with posttraumatic stress disorder: a meta-analysis. J Trauma Stress (2013) 1.11
Risperidone in the management of disruptive behavior disorders. J Child Adolesc Psychopharmacol (2006) 1.11
Methodological issues and controversies in clinical trials with child and adolescent patients with bipolar disorder: report of a consensus conference. J Child Adolesc Psychopharmacol (2003) 1.10
Autism spectrum disorders as a qualitatively distinct category from typical behavior in a large, clinically ascertained sample. Assessment (2009) 1.10
A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression. J Am Acad Child Adolesc Psychiatry (2006) 1.10
Retroviral vector-producing mesenchymal stem cells for targeted suicide cancer gene therapy. J Gene Med (2009) 1.10